Cite
HARVARD Citation
Nakashima, K. et al. (2022). Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: A prospective multicenter cohort study. Human vaccines & immunotherapeutics. 18 (6), p. . [Online].